1. Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer
- Author
-
E González-Jiménez, MJ Titos, R Olivencia-Dueso, S Menjón-Beltrán, [Menjón-Beltrán,S, Olivencia-Dueso,R, González-Jiménez,E, and Titos,MJ] Unidad de Ginecología Oncológica, Hospital Universitario Virgen de las Nieves, Granada, Spain.
- Subjects
Oncology ,medicine.medical_specialty ,education ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2 [Medical Subject Headings] ,Breast cancer ,Stable Disease ,Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized [Medical Subject Headings] ,Surgical oncology ,Trastuzumab ,Internal medicine ,parasitic diseases ,Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis [Medical Subject Headings] ,medicine ,Receptor erbB-2 ,skin and connective tissue diseases ,neoplasms ,Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings] ,business.industry ,Metástasis de la Neoplasia ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings] ,Neoplasias de la Mama ,Femenino ,medicine.disease ,Anticuerpos Monoclonales Humanizados ,Antineoplásicos ,Metastatic breast cancer ,Gemcitabine ,Humanos ,Antimetabolitos Antineoplásicos ,Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastic [Medical Subject Headings] ,Check Tags::Female [Medical Subject Headings] ,sense organs ,business ,geographic locations ,medicine.drug - Abstract
Poster Presentation. This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer. Trastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital. Yes
- Published
- 2007